Indorama Ventures Public Co. Ltd. (IVL), a global chemical producer, reaffirmed at its Annual General Meeting on April 24 in Bangkok, Thailand, its confidence in the company’s “execution-led business strategy and highlighted how its competitive advantages are positioning the company ahead of a recovery in the chemicals industry,” in a news release.
Addressing shareholders, Group CEO Aloke Lohia described 2025 as a defining period of unprecedented challenges and emphasized that IVL has entered a new “execution era” built on radical clarity, disciplined delivery, and structural resilience.
“2025 tested our resilience and challenged our assumptions — but it also became the catalyst for the most profound strategic pivot in our company’s recent history,” said Lohia. “We have done our homework over the last three years. Today, we are fixing our platform to cope with trough margins while simultaneously creating free cash flow. This is the story of our IVL 2.0 transformation strategy and our transition to an execution-led organization defined by accountability and measurable value creation.”
Resilience validated by four ‘moats’
Lohia highlighted the ongoing Iran-related disruptions as a real-time validation of Indorama Ventures’ strategy, particularly the inherent resilience of its globally integrated “local-for-local” operating model. With about 50% of revenue generated in the Americas — where advantaged shale-based feedstocks underpin around 60% of contribution margin — the company continues to benefit from structural cost advantages relative to naphtha-based peers.
Lohia identified four structural “moats” underpinning long-term value creation, including the company’s unique shale-based integration in the U.S., its integrated global business model that spans feedstock to downstream applications; its four diversified business segments as “engines” that serve essential, resilient end-markets; and a disciplined operating rhythm driven by real-time execution and inventory control.
“Our businesses are interconnected through common feedstocks and integration across the ethylene and aromatic value chains,” Lohia said. “This creates a dynamic, interlinked system of competitive advantage that is extremely difficult to replicate.”
Execution discipline
A central pillar of the company’s transformation is its Sales & Operations Execution (S&OE) model, which enables operational agility and improved capital efficiency.
“S&OE allows us to steer around market volatility in real time. By improving inventory velocity and aligning production closely with demand, we reduce exposure to price swings and unlock cash flow,” Lohia said.
This approach supports the company’s deleveraging roadmap, with a target to reduce net debt-to EBITDA to below 3.0x by 2028, while strengthening earnings quality and free cash flow generation.
Reaffirming 2026–2028 targets
Building on the three-year business plan that the company outlined at its Capital Markets Day (CMD) in March, Lohia reaffirmed management’s commitment to self-help driven performance that does not rely on a recovery in the chemical market’s cycle.
“Our financial target is clear — we will double EBITDA from the 2025 trough to THB 64 billion by 2028, while reducing leverage to our target level,” Lohia said. “This will be achieved through five enterprise priorities: structural cost leadership; commercial and manufacturing excellence; portfolio optimization; inventory discipline; and rigorous cash and capital management — consistent with the roadmap presented at the company’s CMD.”
Lohia emphasized that the achievements under IVL 2.0 have made the company stronger and more profitable.
“We are building a faster, leaner, and more profitable company — defined by a culture of performance that will outlast any single individual and deliver sustained value to our shareholders,” he added.
